Gara Jalqabaatti › Dhukkubaa Stargardt › Florida
Qorannoo klinikaalii Dhukkubaa Stargardt Florida keessatti
Qorannoo 8 Dhukkubaa Stargardt f Florida keessatti hirmaatuu jiru.
Magaalota Florida keessatti
Takkalaa qorannoo (Ingiliffa)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 8 hanga 55 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 8 hanga 45 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07425574Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 11-Bit-2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Mud-2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 65 · Saalaa hunda · Haaromfame 19-Ful-2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 65 · Saalaa hunda · Haaromfame 29-Elb-2025 · NCT06942572Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.